tuberculosis dormancy model and drug testing
Drug susceptibility testing for optimising tuberculosis treatment
82
A Mathematical Model of Tuberculosis with Drug Resistance Effects
14
Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex
5
From competency to dormancy: a 3D model to study cancer cells and drug responsiveness
13
Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
8
The implications of model–informed drug discovery and development for tuberculosis
9
Mathematical analysis of a drug resistance in a tuberculosis transmission model
56
Direct susceptibility testing for multi drug resistant tuberculosis: A meta analysis
15
Integration of Mycobacterium tuberculosis Drug Susceptibility Testing and Genotyping with Epidemiological Data Analysis To Gain Insight into the Epidemiology of Drug Resistant Tuberculosis in Malatya, Turkey
5
Drug resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing
6
Discordance across Several Methods for Drug Susceptibility Testing of Drug Resistant Mycobacterium tuberculosis Isolates in a Single Laboratory
8
NON-COMMERCIAL CULTURE AND DRUG-SUSCEPTIBILITY TESTING METHODS FOR SCREENING OF PATIENTS AT RISK OF MULTI-DRUG RESISTANT TUBERCULOSIS
11
Introduction. Keywords drug development, drug-resistant tuberculosis, drug-susceptible tuberculosis, multidrug therapy
8
Evaluation of Molecular Tools for Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Stool Specimens from Patients with Pulmonary Tuberculosis
7
The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis
11
Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon
7
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods
5
Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation
8
Performance of Tuberculosis Drug Susceptibility Testing in U S Laboratories from 1994 to 2008
7
Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems
9